Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
1.685
-0.075 (-4.26%)
Oct 30, 2026, 12:55 PM EDT - Market open
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $103.83 million as of October 30, 2026. It is the 24,509th most valuable company in the world and the 4,034th biggest in the United States. Its market cap has decreased by 59.40% in one year.
Market Cap
103.83M
Enterprise Value
-12.42M
1-Year Change
-59.40%
Global Rank
Country Rank
#4,034 United States
Category
ChartMarket Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $103.83M, a decrease of -77.26%. That is a compound annual growth rate of -12.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 103.83M | -52.48% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Retension Pharmaceuticals | 112.64M |
| Kazia Therapeutics | 111.96M |
| Tiziana Life Sciences | 111.64M |
| Seer, Inc. | 108.53M |
| Minerva Neurosciences | 106.48M |
| Cibus | 105.47M |
| OnKure Therapeutics | 105.09M |
| enGene Therapeutics | 103.88M |